Mighty QUBE's sales channels and functional enhancements
First written in FY2017-Q1. 20 of 26 entries say "Advanced", first in FY2017-Q3. Latest entry: 2026-08-13.
No other company in this theme has enough history to compare yet.
- FY2026AdvancedAnnual report
「As the second phase of M&A, a pillar of the growth strategy, the company made ラジエンスウエア社 a subsidiary and acquired a strong customer base in the Tokyo metropolitan and northern Kanto regions. Using the approximately 475 existing medical-systems customers held by the company as a foundation, it will seek to build recurring revenue by expanding the provision of maintenance and services.」
Regarding the sales and delivery structure for the Mighty series, the business advanced to the stage of expanding recurring maintenance and service revenue and cross-selling after acquiring approximately 475 medical-systems customers through the acquisition of ラジエンスウエア社 as a subsidiary. - 2026-05-14AdvancedResults
「In April 2026, the company began offering a new product, the next-generation model MightyChecker® Cloud X, cloud-based claims inspection software.」
Mightyシリーズについて、次世代クラウド製品の提供を開始し、診療所に加えて小規模病院への展開を進める段階に進んだ。 - FY2026-H1AdvancedAnnual report
「As part of its OEM strategy, on 30 July 2025 the company began providing Mighty QUBE® Hybrid on an OEM basis to medicalforce, a cloud-based electronic medical-records system for private-pay clinics provided by 株式会社メディカルフォース. medicalforce has already been adopted by approximately 600 clinics and, in February 2024, established integration with the Japan Medical Association’s WebORCA. It is being developed as a product capable of supporting both private-pay and insured medical care.」
For Mighty QUBE Hybrid, OEM provision to medicalforce began on 30 July 2025. The company established concrete plans to expand its sales channels by leveraging medicalforce’s installed base of approximately 600 clinics. - FY2025-H1AdvancedAnnual report
「For the next-generation claims-checking system MightyChecker® EX, the company completed the replacement of 200 facilities through an upselling initiative following the end of new sales of the former product, Mighty Checker For ORCA, and continues initiatives to increase revenue per user. It is also strengthening initiatives to acquire direct accounts (direct sales) through the shift to web-based sales and support, promote solution upselling (increasing revenue per customer), and switch to new pricing based on the economic benefits of adopting its solutions. For the ordering-check software Mighty QUBE® Hybrid, the company is pursuing cross-selling by entering into business partnerships, including OEM provision, with electronic medical-records vendors targeting small and medium-sized hospitals. It has now entered into business partnerships with 2 electronic medical-records vendors and is seeking to expand orders. In addition, from the current fiscal year, the company has begun OEM supply to cloud-based electronic medical-records systems specializing in home healthcare, promoting sales of Mighty QUBE® Hybrid in the clinic market.」
MightyChecker EX completed replacements at 200 facilities, while Mighty QUBE Hybrid entered into business partnerships with 2 electronic medical-records vendors and began OEM supply to a cloud-based electronic medical-records system for home healthcare. - FY2024-Q3AdvancedAnnual report
「In addition, from the third quarter, the company began full-scale cross-selling of Mighty QUBE® Hybrid, targeting small and medium-sized hospitals, through a partnership with an existing electronic medical-records vendor for MightyChecker®. Of several inquiries, the company entered into a business partnership with 1 company. Including facilities that have and have not adopted electronic medical records, the market for Mighty QUBE® Hybrid is expected to be approximately ¥6.2 billion, and the company will seek to expand orders further.」
Full-scale cross-selling of Mighty QUBE Hybrid began in the third quarter, and a business partnership was concluded with 1 company. With the market estimated at approximately ¥6.2 billion, the business advanced to the stage of pursuing further order growth. - FY2023-Q3RestatedAnnual report
「In addition to expanding horizontally within these major medical groups, we are promoting the acquisition of additional direct accounts (direct sales) and the upselling of solutions (increasing revenue per customer) by shifting to web-based sales and support as part of our response to COVID-19. Going forward, we will strengthen initiatives for a new pricing policy based on the economic benefits of adopting our solutions.」
Continued descriptions of horizontal expansion within medical groups, web-based sales and support, direct sales, upselling and the strengthening of the new pricing policy. - FY2023-Q2Promote the new pricing policy from the second half of the fiscal year.Annual report
「Going forward, we will continue to promote the acquisition of direct sales, the implementation of pricing policies and the upselling of solutions (increasing revenue per customer), while also promoting a new pricing policy from the second half of the fiscal year based on the economic benefits of adoption.」
While continuing direct sales, pricing policies and upselling, the company clearly stated that it would promote a new pricing policy from the second half of the fiscal year based on the benefits of adoption. - FY2023-Q1AdvancedAnnual report
「In addition, during the first quarter, the company began taking advance orders for the new Mighty QUBE (provisional name), announced at a trade show in July 2022, which supports the reform of physicians’ working styles. Going forward, the product is expected to expand and gain market penetration as one of the company’s new strategic solutions.」
Advance orders began for the new Mighty QUBE (provisional name), which supports the reform of physicians’ working styles. - FY2022AdvancedAnnual report
「In addition, the full-scale launch of OEM provision of the cloud-based claims-audit service Mighty Checker ®Cloud has paid off, and sales related to the service have been growing steadily.」
In addition to the existing horizontal expansion within medical groups, web-based sales, direct sales, pricing policies and upselling, the company moved to full-scale OEM provision of MightyChecker Cloud, resulting in sales growth. - FY2022-Q2RestatedAnnual report
「In addition to expanding horizontally within these major medical groups, we will further promote the acquisition of direct accounts (direct sales), the implementation of pricing policies and the upselling of solutions (increasing revenue per customer) by shifting to web-based sales and support as part of our response to COVID-19.」
Continued horizontal expansion within medical groups, web-based sales and support, direct sales, pricing policies and increases in revenue per customer through upselling. - FY2022-Q1AdvancedAnnual report
「In addition to expanding horizontally within these major medical groups, we will further promote the acquisition of direct accounts (direct sales), the implementation of pricing policies and the upselling of solutions (increasing revenue per customer) by shifting to web-based sales and support as part of our response to COVID-19.」
In addition to horizontal expansion within major medical groups, web-based sales and support and direct sales, concrete measures were established to increase revenue per customer through pricing policies and upselling. - FY2021-Q3AdvancedAnnual report
「In addition to expanding horizontally within these major medical groups, we will further promote the acquisition of direct accounts (direct sales), the implementation of pricing policies and the upselling of solutions (increasing revenue per customer) by shifting to web-based sales and support as part of our response to COVID-19.」
In addition to the existing horizontal expansion within medical groups, web-based sales and support and direct sales, the implementation of pricing policies and solution upselling were clearly identified. - FY2021-Q2AdvancedAnnual report
「In addition to expanding horizontally within these major medical groups, we will further promote the acquisition of direct accounts (direct sales) and the upselling of solutions (increasing revenue per customer) by shifting to web-based sales and support as part of our response to COVID-19.」
In addition to horizontal expansion within medical groups and the shift to web-based sales and support, direct-sales acquisition and increasing revenue per customer through solution upselling were clearly identified. - FY2021-Q1AdvancedAnnual report
「In addition to expanding horizontally within these major medical groups, we will further promote the acquisition of direct accounts (direct sales) by shifting to web-based sales and support as part of our response to COVID-19.」
In addition to horizontal expansion within major medical groups, the shift to web-based sales and support and the acquisition of direct sales were developed into concrete new sales-channel initiatives. - FY2020RestatedAnnual report
「In addition to these rollouts across major medical groups, the company has begun collaborating with multiple financial institutions to promote direct sales and strengthen marketing.」
The company continues to state its initiatives involving rollouts across major medical groups and the strengthening of direct sales and marketing through collaboration with financial institutions. - FY2020-Q3AdvancedAnnual report
「In addition to these rollouts across major medical groups, the company has begun collaborating with multiple financial institutions to promote direct sales and strengthen marketing, and will pursue measures aimed at further improving its profit margin.」
In addition to rollouts across major medical groups, the company began collaborating with multiple financial institutions, providing concrete detail on direct sales and strengthened marketing. - FY2020-Q2AdvancedAnnual report
「Going forward, the company will roll out the product across major medical groups and strengthen marketing for direct sales through collaboration with financial institutions and others, with the aim of further improving its profit margin.」
In addition to rollouts across major medical groups, the company specified measures to strengthen direct-sales marketing through collaboration with financial institutions and others, providing concrete detail on its sales-channel initiatives. - FY2020-Q1AdvancedAnnual report
「In October 2018, the company launched the next-generation claims-checking system MightyChecker® EX and received numerous inquiries, including from major group hospitals. It has now decided to introduce the system at several hospitals within medical groups with top-tier sales, and will work to expand sales further, including through rollouts across major medical groups.」
For MightyChecker EX, the company specified decisions to introduce the product at several hospitals within major medical groups and rollouts across those groups. - FY2019-Q3AdvancedAnnual report
「In October 2018, the company began selling MightyChecker® EX, a new product in the MightyChecker® series of claims inspection software and a next-generation claims-checking system incorporating AI-based claims inspection, with functions designed to meet the needs of medical institutions.」
MightyChecker EX began being sold in October 2018, providing concrete product functionality as a next-generation claims-checking system incorporating AI functions. - FY2019-Q2AdvancedAnnual report
「At the International Modern Hospital Show 2018 held in July 2018, the company exhibited MightyChecker EX as a reference product. The product enhanced the functions of the former Mighty Checker, adding learning capabilities and support for group medical institutions, and received a favorable response. The company continues to develop products from the user's perspective.」
For MightyChecker, the company exhibited MightyChecker EX as a reference product in July 2018, incorporating learning capabilities and support for group medical institutions, providing concrete evidence of enhanced product functionality. - FY2018RestatedAnnual report
「The company is promoting differentiation from competitors by providing highly convenient products and services from the user's perspective, including claims assessment and analysis functions and cloud, ORCA and dental versions, together with detailed and comprehensive user support.」
The company continues its policy of differentiating existing products, including Mighty QUBE, through functionality, delivery formats and user support. - FY2017AdvancedAnnual report
「The company is promoting differentiation from competitors by providing highly convenient products and services from the user's perspective, including claims assessment and analysis functions and cloud, ORCA and dental versions, together with detailed and comprehensive user support.」
The company specified enhancements to products and services, including cloud, ORCA and dental versions, claims assessment and analysis functions, and user support. - FY2017-Q3AdvancedAnnual report
「The company is also accelerating development aimed at enhancing the functions of existing products in order to provide highly convenient products and services from the user's perspective.」
The company described progress in accelerating development aimed at enhancing the functions of existing products. This remains an initiative to improve the convenience of existing products, including Mighty QUBE. - FY2017-Q1First statedAnnual report
「For Mighty QUBE®, the company is also working on proposals to electronic medical record vendors for clinics and functional enhancements based on the needs of existing customers.」
The company described proposals to electronic medical record vendors and functional enhancements based on existing customer needs as sales and product initiatives.